Fundz
Funding, M&A and exec moves matched to your market, guaranteed to pay for itself in a year, or we refund it. See terms for full details.See plans →

Piramal Pharma acquires additional stake in Yapan Bio

PRIVATEAug 19, 2026about 4 hours ago

Acquiring Company

Piramal Pharma Solutions

Acquired Company

Yapan Bio Private Limited

MumbaiHyderabadManufacturingBiotechnologyPharmaceuticalManufacturingBiotechnology

Description

Piramal Pharma Ltd. completed the acquisition of an additional 40.67% stake in Yapan Bio Private Limited on August 18, 2026, for 76 crore INR, totaling about 7.95 million USD. With this acquisition, Piramal now holds 74% of Yapan Bio, making it a subsidiary. The move strengthens Piramal's long-term strategy in the biological product sector.

Company Information

Company

Piramal Pharma Solutions

Location

Mumbai, Maharashtra, India

About

Piramal Pharma Solutions is a leading global Contract Development and Manufacturing Organization (CDMO) that specializes in offering comprehensive services ranging from drug substance development to commercial supply. It is a part of Piramal Pharma Ltd. and serves clients worldwide across various therapeutic areas. The company is known for its innovative solutions and commitment to quality.

Don't miss Piramal Pharma Solutions's next move

Get an email the moment Piramal Pharma Solutions makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Nikita
Senior decision-maker at this company
••••••••@••••••••

See Nikita's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Piramal Pharma Solutions's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Yapan Bio Private Limited?

Yapan Bio Private Limited was acquired by Piramal Pharma Solutions, based in Mumbai. The deal was reported on August 19, 2026. Piramal Pharma Solutions is a leading global Contract Development and Manufacturing Organization (CDMO) that specializes in offering comprehensive services ranging from drug substance development to commercial supply. Piramal Pharma Solutions is privately held and operates in Manufacturing.

When did Piramal Pharma Solutions acquire Yapan Bio Private Limited?

Piramal Pharma Solutions's acquisition of Yapan Bio Private Limited was reported on August 19, 2026. Piramal Pharma Ltd. completed the acquisition of an additional 40.67% stake in Yapan Bio Private Limited on August 18, 2026, for 76 crore INR, totaling about 7.95 million USD. With this acquisition, Piramal now holds 74% of Yapan Bio, making it a subsidiary. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Yapan Bio Private Limited do?

Yapan Bio Private Limited is a Contract Development and Manufacturing Organization (CDMO) specializing in vaccines and biologics. The company is focused on providing large molecule capabilities and plays a key role in advancing biologic therapies. It is privately held, operating in Manufacturing, and is based in Hyderabad.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.